Medicine and Dentistry
Acute Lymphoblastic Leukemia
46%
Flow Cytometry
32%
CD8+ T Lymphocyte
28%
Epstein Barr Virus
28%
Autologous Stem Cell Transplantation
28%
Bacteremia
28%
Body Fluid
28%
Diffuse Large B-Cell Lymphoma
28%
Multiple Myeloma
28%
Acute B-Cell Lymphoblastic Leukemia
28%
Treatment Response
28%
Bone Marrow Mesenchymal Stem Cell
28%
Mesenchymal Stem Cell
28%
Tumor Necrosis
25%
Gene Expression Profiling
21%
Disease
20%
T Cell
14%
CD8 Antigen
14%
Overall Survival
14%
Immunophenotyping
12%
Hematologic Malignancy
12%
Solid Malignant Neoplasm
11%
T Lymphocyte Receptor
10%
Interleukin 2
10%
CD20
10%
T Lymphocyte
7%
Multivariate Analysis
7%
Malnutrition
7%
Differential Gene Expression
7%
Aplasia
7%
Mucositis
7%
Absence
7%
Receptor Type Tyrosine Protein Phosphatase C
7%
CD20 Antigen
7%
Spontaneous Remission
7%
Survival Rate
7%
Common Acute Lymphoblastic Leukemia Antigen
7%
Ethnic Groups
7%
Event Free Survival
7%
Microarray Analysis
7%
Prognostic Factor
7%
Gene Expression
7%
Quantitative Reverse Transcription Polymerase Chain Reaction
7%
Ascites Fluid
5%
Immune Deficiency
5%
Cerebrospinal Fluid
5%
Leukemia
5%
Pericardial Fluid
5%
Myeloma
5%
Chronic Leukemia
5%
Immunology and Microbiology
B Cell
100%
Epstein Barr Virus
57%
T Cell
50%
T Cell Receptor
39%
Cell Count
31%
Tumor Necrosis Factor
31%
CD8+ T Lymphocyte
28%
Regulatory T Cell
28%
Human Immunodeficiency Virus
28%
Overall Survival
28%
Mesenchymal Stem Cell
28%
CD8
14%
CD19
12%
Interleukin 2
10%
Cytotoxic T-Cell
9%
CD20
9%
Coculture
9%
Leukocyte Count
9%
CD4
9%
Precursor
8%
Immune Response
8%
Cytokine
7%
Receptor Type Tyrosine Protein Phosphatase C
6%
CD20 Antigen
6%
Common Acute Lymphoblastic Leukemia Antigen
6%
Leukemia Cell
6%
Viral Load
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
28%
Bacteremia
28%
Flow Cytometry
28%
Multiple Myeloma
28%
Disease
20%
Remission
14%
Overall Survival
14%
Hematologic Malignancy
12%
Solid Malignant Neoplasm
11%
Event Free Survival
7%
Mucosa Inflammation
7%
Aplasia
7%
Malnutrition
7%
Survival Rate
7%
Myelodysplastic Syndrome
5%
Pericardial Effusion
5%
Myeloma
5%
Ascites
5%
Immune Deficiency
5%
Chronic Leukemia
5%
Acute Leukemia
5%
Leukemia
5%
Autoimmune Disease
5%
Neoplasm
5%
